Vadim Markovtsov, PhD

Rigel Pharmaceuticals, Inc.
South San Francisco, California, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 88 - Fostamatinib for the Treatment of Hospitalized Patients With COVID-19 Who Required Oxygen Supplementation: Results of a Phase 3 Trial

  Thursday, October 12, 2023
  11:15 AM – 11:30 AM US ET